APAC is expected to be the fastest-growing market. The global next-generation sequencing (NGS) market is projected to grow ...
Immune Checkpoint Blockade (ICB) has reshaped cancer care and can deliver durable remission in malignancies such as melanoma and non-small cell lung cancer.